AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?

Anita Busacca  1     laura guida  1     Lucio Carrozza  1     Vincenza Calvaruso  1     Maria Cappello  1    
1 University of Palermo,Palermo,Italy

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing